EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Use of arsenic trioxide in the treatment of acute promyelocytic leukemia I Arsenic causes both apoptosis and partial differentiation of NB4 and fresh APL cells in vitro and vivo



Use of arsenic trioxide in the treatment of acute promyelocytic leukemia I Arsenic causes both apoptosis and partial differentiation of NB4 and fresh APL cells in vitro and vivo



Blood 88(10 SUPPL 1 PART 1-2): 219A




(PDF emailed within 1 workday: $29.90)

Accession: 034149137

Download citation: RISBibTeXText



Related references

Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells. Plos One 10(6): E0130343-E0130343, 2016

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97(1): 264-269, 2001

Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro. European Review for Medical and Pharmacological Sciences 22(19): 6412-6421, 2018

Complete remission after clinically induced differentiation and apoptosis in acute promyelocytic leukemia by arsenic trioxide. British Journal of Haematology 102(1): 225, July 1, 1998

In vitro study of the effects of arsenic trioxide combined with 8-CPT-cAMP on differentiation induction in retinoic acid resistant acute promyelocytic leukemia cells. Zhonghua Xue Ye Xue Za Zhi 24(1): 6-9, 2003

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Analytical and Bioanalytical Chemistry 405(6): 1903-1911, 2013

Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chemical Research in Toxicology 17(1): 95-103, 2004

The in vitro study of apoptosis induced with arsenic trioxide and other Chinese medications in acute promyelocytic leukemia and chronic myelocytic leukemia. Blood 92(10 SUPPL 1 PART 1-2): 193B, Nov 15, 1998

Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?. Leukemia & Lymphoma 55(5): 977-978, 2014

Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment. Talanta 184: 446-451, 2018

Arsenic trioxide-induced apoptosis of acute promyelocytic leukemic cells is associated with reduced AKT phosphorylation and modified by arsenic methylation. Blood 98(11 Part 1): 306a-307a, November 16, 2001

Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Environmental Toxicology 28(5): 267-275, 2013

Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment. Leukemia Research 32(2): 357-358, 2007

Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RAR Protein in Acute Promyelocytic Leukemia Cells. Jnci Journal of the National Cancer Institute 90(2): 124-133, 1998

Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia (Basingstoke) 17(7): 1333-1337, July, 2003